Night Blindness Treatment Market Report 2025 – Strategic Data for Growth and Expansion

 Unlock 30% off global market reports with code ONLINE30 — get insights on tariff changes, macro trends, and global economic shifts.

 

 What is the anticipated market size of the night blindness treatment industry over the next few years?
 The night blindness treatment market size has grown strongly in recent years. It will grow from $3.95 billion in 2024 to $4.21 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to rising prevalence of vitamin A deficiency, growth in the geriatric population prone to night vision problems, expansion of healthcare infrastructure, increasing focus on nutritional interventions for vision health, rising incidence of retinitis pigmentosa.
 
 The night blindness treatment market size is expected to see strong growth in the next few years. It will grow to $5.39 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to increasing adoption of advanced diagnostic technologies, increasing awareness campaigns about eye health, rising demand for personalized medicine, growth in the number of eye care clinics and facilities, growth in healthcare infrastructure development. Major trends in the forecast period include adoption of advanced diagnostic technologies, implementation of personalized treatment, development of gene therapy and stem cell treatments, integration of wearable technology for real time monitoring, development of multi-disciplinary clinics.
 
 Download Your Free Sample PDF:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=18413&type=smp
 
 What emerging drivers are expected to shape the future of the night blindness treatment market?
 The increasing prevalence of cataracts is expected to propel the growth of the night blindness treatment market going forward. Cataracts refer to a condition where the eye’s lens becomes cloudy, leading to impaired vision. The increased exposure to ultraviolet (UV) light from the sun, smoking, and poor diet contribute to the development of cataracts. Cataracts reduce the eye’s ability to distinguish between different shades of light and dark, which is crucial for night vision. This decreased contrast sensitivity makes navigating and recognizing objects in low-light environments harder. For instance, in July 2023, according to the 2021–23 National UK Eye Care Statistics Survey conducted by the Well-being of Future Generations Act (WFG), a UK-based government agency, there were an estimated 16,500 (16,510) cataract admissions in 2022–23, an increase of 23.7% from the previous year. Therefore, the increasing prevalence of cataracts is driving the night blindness treatment market.
 
 What emerging segments are shaping the future landscape of the night blindness treatment industry?
 The night blindness treatment market covered in this report is segmented –
 
 1) By Treatment: Medication, Surgery, Other Treatments
 2) By Diagnosis: Blood Tests, Color Vision Testing, Pupil Light Reflex, Refraction, Retinal Exam, Electroretinogram (ERG), Other Diagnoses
 3) By Symptom: Eye Pain, Vomiting, Cloudy Vision, Halos, Light Sensitivity, Distance Vision Problem, Headache, Other Symptoms
 4) By End User: Clinic, Hospital, Other End Users
 
 Subsegments:
 1) By Medication: Vitamin A Supplements, Retinoid Therapy, Beta-Carotene Supplements, Anti-Glaucoma Medications, Other Pharmaceutical Treatments
 2) By Surgery: Cataract Surgery, Retinal Surgery, Corneal Transplantation, LASIK Surgery
 3) By Other Treatments: Light Therapy, Gene Therapy, Low Vision Aids And Assistive Devices, Nutritional Therapy
 
 
 View The Full Market Report:
 https://www.thebusinessresearchcompany.com/report/night-blindness-treatment-global-market-report
 
 What technological trends are expected to redefine the night blindness treatment market?
 Major companies operating in the night blindness treatment market are developing innovative genetic therapies to address the underlying genetic mutations responsible for enhancing treatment efficacy for improved patient outcomes. Genetic therapies help in treating night blindness by targeting and repairing specific genetic mutations that affect retinal function, potentially restoring vision in individuals with inherited retinal disorders such as retinitis pigmentosa. For instance, in August 2023, HuidaGene Therapeutics., a US-based clinical-stage biotechnology company, introduced HG004, a gene therapy designed to treat inherited retinal diseases such as Leber’s congenital amaurosis. This therapy has shown superiority over existing treatments in preclinical studies, aiming to restore retinal function and alleviate night blindness and other conditions associated with RPE65-induced impairments.
 
 How are key players in the night blindness treatment market strengthening their market position?
 Major companies operating in the night blindness treatment market are Johnson & Johnson Private Limited, F. Hoffmann-La Roche Ltd., Bayer AG, Abbott Laboratories, Novartis AG, Boehringer Ingelheim, Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Bausch Health Companies Inc., Eisai Co. Ltd, Cipla Inc., Nature’s Way, Spark Therapeutics Inc., Garden of Life, Apellis Pharmaceuticals Inc, Solgar, Acucela Inc., Swanson Health Products, NOW Foods
 
 Which geographic areas are contributing significantly to the growth of the night blindness treatment sector?
 North America was the largest region in the night blindness treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the night blindness treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 How Can Companies Use The Night Blindness Treatment Market Report to Drive Business Results?
 This report provides actionable insights tailored for business use — not academic analysis. Companies can leverage the data to:
 • Time market entry or expansion using growth forecasts and CAGR trends.
 • Develop competitive products by tracking key technology shifts and user preferences.
 • Tailor regional strategies with in-depth geographic data and local market dynamics.
 • Benchmark and plan partnerships using competitive landscape insights.
 
 Purchase The Report And Get A Swift Delivery:
 https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18413
 
 Need Customized Data On Night Blindness Treatment Market?
 For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
 
 Request Customized Data:
 https://www.thebusinessresearchcompany.com/customise?id=18413&type=smp
 
 About The Business Research Company:
 
 With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
 
 Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
 
 Contact Us:
 
 The Business Research Company
 
 https://thebusinessresearchcompany.com/
 
 Americas +1 310–496-7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267
 Email us at info@tbrc.info
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company